KAYLA LORENZEN: Open Payments
NPI 1538785647 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 28 payments from 13 companies in 2025. Trend: 2023 $1,057 · 2024 $1,055 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $251 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| Corcept Therapeutics | 1 | $127 |
| ABIOMED | 1 | $100 |
| Lilly USA, LLC | 4 | $69 |
| PFIZER INC. | 2 | $48 |
| ABBVIE INC. | 2 | $48 |
| GENZYME CORPORATION | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: UPTRAVI, Korlym, Ozempic, Wegovy, JARDIANCE, NURTEC ODT, Rybelsus, MOUNJARO.
Industry payments across FL — which companies pay providers there.
